Supply Chain

Here are six drug and medical device companies that made headlines in the past week.

Woonsocket, R.I.-based CVS Health saw operating income decrease in the third quarter of fiscal year 2017 as its retail business faced reimbursement pressure and rising expenses related to recent hurricanes.

The Republican Tax Cuts and Jobs Act, unveiled in the House Thursday, would cut taxes by nearly $1.5 trillion over the next 10 years — impacting numerous taxpayers across the nation, including pharmaceutical companies, according to STAT.

Arriva Medical and American Medical Supplies, subsidiaries of Alere, are closing facilities in Florida, according to a Sun Sentinel report.

Senators introduced a bipartisan bill Tuesday calling on the Food and Drug Administration and CMS to create an action plan to reduce healthcare spending stemming from wasteful drug delivery practices.

Here are six drugmakers' financial results for the third quarter of fiscal year 2017.

Here are six articles Becker's Hospital Review published in the last week, highlighting why drugmakers would welcome Amazon's pharmacy market entrance and Merck's $135M sales loss attributed to the NotPetya cyberattack.

Here are the three latest drugs approved by the Food and Drug Administration since Oct. 23.

EpiPen failures — specifically their inability to deploy correctly — were linked to seven patient deaths so far this year, according to FDA reports obtained by Bloomberg.

HHS' Office of the Assistant Secretary for Preparedness and Response activated its Emergency Prescription Assistance Program to help uninsured U.S. Virgin Island residents recovering from Hurricane Maria obtain the critical prescription medications they need.